Skip to content

BWAY

BrainsWay Ltd.

NASDAQ · ILHealthcareMedical - Devices
$16.50+4.90%

Price as of Jul 20, 2026

BWAY growth

BrainsWay Ltd. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+29.4%
EBITDA
+90.6%
EBIT
+206.9%
EPS
+182.0%
Free cash flow
+42.8%
Operating cash flow
+16.9%

Forward estimates

Revenue
+29.6%
EBITDA
EPS
-13.9%

Three-year CAGR

Revenue
+24.3%
EBITDA
+113.9%
EBIT
+210.8%
Net income
+161.3%
EPS
+365.1%
Free cash flow
+152.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.